48.85SEK+1.24%Mkt Cap: 1.17B SEKP/E: —Last update: 2026-05-13
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. …
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)12.27
PEG—
P/B2.89
P/S3.62
EV/EBITDA37.34
EV/Revenue3.28
EPS (TTM)-0.72
EPS (Forward)4.10
Cash Flow & Leverage
FCF Yield-1.30%
FCF Margin-4.70%
Operating CF7.39M SEK
CapEx (TTM)23.47M SEK
Net Debt/EBITDA-3.79
Net Debt-107.83M SEK
Technical
SMA 5047.72 (+2.4%)
SMA 20057.91 (-15.6%)
Beta0.45
S&P 52W Chg24.23%
Avg Vol (30d)17.11K
Avg Vol (10d)14.26K
Technical Indicators
RSI (14)50.5
MACD0.2822
MACD Signal0.4206
MACD Hist.-0.1384
BB Upper51.70 SEK
BB Middle49.39 SEK
BB Lower47.08 SEK
BB Width9.36%
ATR (14)2.085 SEK
Vol Ratio (20d)0.14x
52W Range
41.0018% of range85.80
52W High85.80 SEK
52W Low41.00 SEK
Profitability
Gross Margin66.64%
EBITDA Margin8.80%
Profit Margin-5.33%
Oper. Margin-3.98%
ROE-4.13%
ROA-3.49%
Revenue Growth27.10%
Earnings Growth—
Balance Sheet
Debt/Equity0.03
Current Ratio3.96
Quick Ratio3.06
Book Value/Sh17.41 SEK
Cash/Share5.192 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.23.27M
Float16.63M
Insiders42.64%
Institutions19.74%
Analyst Consensus
Rating—
Target (Mean)94.50 SEK
Target Range82.00 SEK – 107.00 SEK
# Analysts2
Company
Market Cap1.17B SEK
Enterprise Value1.06B SEK
Revenue (TTM)323.56M SEK
Gross Profit208.81M SEK
Net Income (TTM)-16.71M SEK
Revenue/Share13.90 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees144
Last Price48.85 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—